Daily Tech News Seychelles: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Daily Tech News Seychelles.

Press releases published on September 8, 2026

8 minutes ago

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event

Indeterminate GlobeNewswire

8 minutes ago

Lantronix CEO to Participate in Upcoming Investor and Industry Events

Indeterminate GlobeNewswire

9 minutes ago

Microchip’s 1.2V Clock Buffers Link Latest SoCs and FPGAs with Higher Voltage Components

Indeterminate GlobeNewswire

12 minutes ago

Invivyd to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

13 minutes ago

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Indeterminate GlobeNewswire

13 minutes ago

Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics

Indeterminate GlobeNewswire

13 minutes ago

LiveU, AP bring new connectivity, workflow tech to global newsgathering, deploying largest LU900Q fleet worldwide

Indeterminate GlobeNewswire

13 minutes ago

Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

13 minutes ago

CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

13 minutes ago

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

Indeterminate GlobeNewswire

13 minutes ago

Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

Indeterminate GlobeNewswire

13 minutes ago

Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

13 minutes ago

BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer

Indeterminate GlobeNewswire

13 minutes ago

Cartesian Therapeutics Announces New Employment Inducement Grants

Indeterminate GlobeNewswire

13 minutes ago

Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer

Indeterminate GlobeNewswire

13 minutes ago

BrainChild Bio Closes $116 Million Series A Financing

Indeterminate GlobeNewswire

13 minutes ago

Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis

Indeterminate GlobeNewswire

13 minutes ago

NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director

Indeterminate GlobeNewswire

13 minutes ago

Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC

Indeterminate GlobeNewswire

13 minutes ago

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

Indeterminate GlobeNewswire